Home >  Orthopaedics MDTV >  Orthopaedics Shorts >  Predictive Biomarkers May...

Predictive Biomarkers May Support Potential for "Personalized Medicine Approach" in RA Patients, Study Reveals

By - Dr. Bhumika Maikhuri
Published On 2024-10-01 02:15 GMT   |   Update On 2024-10-01 06:44 GMT
Advertisement

A study published by researchers in Trinity College Dublin and St Vincent's University Hospital proposes a better understanding of the site of inflammation in rheumatoid arthritis which will allow for the development of new treatment strategies or predictive biomarkers which could support the potential for a ‘personalised medicine’ approach. The study was published in the journal Science Advances. In India, the prevalence of rheumatoid arthritis is estimated to be 0.7% which is higher than the global prevalence of 0.46%

The team performed an in-depth investigation of a specific population of cells: ‘the macrophages’ that reside in the synovium of Rheumatoid arthritis patients, ‘individuals-at-risk’ of RA, and healthy controls. Researchers demonstrated for the first time, the presence of a dominant macrophage subtype (CD40-expressing CD206+CD163+) in the inflamed Rheumatoid arthritis synovium, which importantly was associated with disease activity and treatment response.
Advertisement
The team identified that these cells are resident in the joint which, in health plays a protective role, but in disease - for reasons we are unsure of - become pro-inflammatory, and release proteins called cytokines that induce inflammation, and also can activate the invasive fibroblast cell type which leads to cartilage and bone destruction.
Researchers identified that the pro-inflammatory status of these macrophages is maintained by specific signaling and metabolic pathways within the joint, the targeting of which may induce the resolution of inflammation. Importantly the team identified that these changes in the macrophage status occurred pre-disease onset.
Combined, these findings identify the presence of an early pathogenic macrophage cell/gene signature that shapes the Rheumatoid arthritis joint inflammatory environment and represents a unique opportunity for early diagnosis and therapeutic intervention.
Reference: Loss of synovial tissue macrophage homeostasis precedes rheumatoid arthritis clinical onset. https://www.science.org/doi/epdf/10.1126/sciadv.adj1252
Full View
Tags:    
Article Source : Science Advances

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr. Bhumika Maikhuri

Dr Bhumika Maikhuri is an orthodontist with 2 years of clinical experience. She is also working as a medical writer and anchor at Medical Dialogues. She has completed her BDS from Dr D.Y. Patil Medical College and Hospital and MDS from Kalinga Institute of Dental Sciences. She has a few publications and patents to her credit. Her diverse background in clinical dentistry and academic research uniquely positions her to contribute meaningfully to our team.

Comments Policy
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

Rheumatoid Arthritis Cases Rise by 13 Percent Globally, Affecting Younger Populations: Study

Simple Routine Habit May Reduce the Risk of Chronic Lower Back Pain: Study Shows

Alkem's Revolutionary therapy TERIPARATIDE-GEMFRAC for weak bones now more accessible to all Indians

Walking in the Park May Ease Chronic Back Pain: Study Finds

Knees at Risk: Study Highlights Top Triggers of Osteoarthritis and How Diet May Help

Stronger Bones in Older Women Linked to Mediterranean Diet and Exercise: Study Finds

X-Rays Often Enough for Back Pain Diagnosis: Study Finds

Biosimilar Denosumab of Alkem (Denuril) shows Comparable Efficacy in Treating Postmenopausal Osteoporosis in Indian Women